Startups channel feed – Endpoints News

Startups channel feed

Exclusive: After Amgen exit, father-son duo gets Lightspeed backing to fund remaining Teneobio 'babies'

3 years ago

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D

3 years ago

Armed with library of molecular glues, Degron launches out of a Shanghai lab

3 years ago

Big names, big backers: David Baker joins OrbiMed, F-Prime, Khosla and others as protein-ligand biotech launches

3 years ago

RA Capital backs a Philly biotech's $118M crossover as it aims to break into the hypertension space

3 years ago

German startup jumps into the hot radiopharma space with a former Ipsen compound as lead program

3 years ago

A former Merck director's Pfizer-backed biotech will take on his old bosses in nascent LILRB field

3 years ago

Gene therapy biotech looking to bypass viral delivery wins investor approval, bagging Series A

3 years ago

Michael Severino trades in AbbVie perch for CEO role at Flagship’s gene medicines biotech Tessera

4 years ago

Samantha Truex officially unwraps Upstream Bio, her secretive, OrbiMed-backed biotech with $200M in the bank

4 years ago

Bay Area genomics startup emerges from stealth with $600M in the bank and promising a '$100 genome' test

4 years ago

Peptide biotech gets renewed support from Bristol Myers, others to bankroll multiple oncology clinical programs

4 years ago

Sequoia China leads $37M infusion into radiopharmaceuticals player setting up shop in China and Belgium

4 years ago

Flagship's latest biotech could turn some of the thousands of new proteins it discovered into therapies — and it has $75M to start

4 years ago

This time around, Lyrica's inventor is developing his Northwestern discoveries at his own biotech

4 years ago

Former Principia team looks to shake up covalent small molecules again, this time at 'earthquake' scale

4 years ago

They sold their last biotech to Merck. Now they're back with a PARP outfit named after a London street

4 years ago

A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General

4 years ago

Not one, not two, but three — biotech claims it will pursue CARs T, M and NK all at once

4 years ago

Flagship builds a new startup out of pieces from 2 of its biotechs. And a Roche vet leaves to do something new

4 years ago

Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials

4 years ago

Chinese pharma giant Hengrui launches new company for globalization play — with a Merck KGaA vet at the helm

4 years ago

Starna Therapeutics emerges with financing for mRNA vaccine and therapies

4 years ago

With $270M in new funds, Shankar Ramaswamy looks beyond Roivant in scaling his gene therapy 'consolidated engine'

4 years ago

First page Previous page 39 40 414243 44 45 Next page Last page